Mercaptopurine did not overall reduce postoperative recurrence of Crohn's disease, but the data suggest an effect among cigarette smokers.
http://ift.tt/2fpNfNr
Τετάρτη 27 Σεπτεμβρίου 2017
A randomised, double-blind, parallel-group trial to assess mercaptopurine versus placebo to prevent or delay recurrence of Crohn’s disease following surgical resection (TOPPIC).
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου